Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
600276 Jiangsu Hengrui Pharmaceuticals
- 48.04
- -0.11-0.23%
Market Closed Dec 12 15:00 CST
306.45BMarket Cap56.25P/E (TTM)
48.15High47.60Low361.61KlotVolume48.15Open48.15Pre Close1.73BTurnover0.57%Turnover Ratio71.28P/E (Static)6.38BShares57.5352wk High7.00P/B306.45BFloat Cap35.3152wk Low52.97Limit Up6.38BShs Float96.71Historical High43.34Limit Down1.14%Amplitude-0.95Historical Low0.20Dividend TTM47.91Avg Price164.51KlotAsk0.42%Div YieldTTM100Lot Size178.63KlotBid
Jiangsu Hengrui Pharmaceuticals Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 18.67%20.19B | 21.78%13.6B | 9.20%6B | 7.26%22.82B | 6.70%17.01B | 9.19%11.17B | 0.25%5.49B | -17.87%21.28B | -21.06%15.95B | -23.08%10.23B |
| Operating revenue | 18.67%20.19B | 21.78%13.6B | 9.20%6B | 7.26%22.82B | 6.70%17.01B | 9.19%11.17B | 0.25%5.49B | -17.87%21.28B | -21.06%15.95B | -23.08%10.23B |
| Other operating revenue | ---- | 1,077.05%1.47B | ---- | 611.05%442.6M | ---- | 6,559.70%124.6M | ---- | -50.29%62.25M | ---- | -94.61%1.87M |
| Total operating cost | 13.81%15.09B | 11.77%9.76B | 4.91%4.41B | 2.63%18.21B | 5.49%13.26B | 9.27%8.73B | 1.18%4.21B | -18.57%17.75B | -17.95%12.57B | -21.40%7.99B |
| Operating cost | 6.61%2.83B | 5.87%1.87B | 9.70%942.85M | 1.11%3.53B | -0.42%2.66B | 4.83%1.77B | 0.49%859.52M | -6.82%3.49B | -2.19%2.67B | -3.78%1.69B |
| Operating tax surcharges | 5.95%172.41M | 4.88%114.95M | 13.86%58.02M | 15.16%219.26M | 13.07%162.73M | 17.68%109.61M | 0.68%50.95M | -5.66%190.39M | -8.27%143.92M | -12.02%93.14M |
| Operating expense | 12.96%6.11B | 7.06%3.94B | 5.66%1.76B | 3.12%7.58B | 4.78%5.41B | 12.61%3.68B | -5.05%1.67B | -21.70%7.35B | -26.22%5.16B | -29.98%3.27B |
| Administration expense | 11.83%1.87B | 8.31%1.17B | 5.61%576.3M | 4.79%2.42B | 14.14%1.68B | 10.98%1.08B | -2.43%545.67M | -19.36%2.31B | -4.57%1.47B | -16.09%976.71M |
| Financial expense | -20.58%-447.89M | -56.76%-382.22M | -117.50%-148.64M | -1.60%-478.39M | -0.12%-371.46M | -10.47%-243.82M | 7.35%-68.34M | -39.33%-470.87M | -52.72%-371.03M | -106.76%-220.7M |
| -Interest expense (Financial expense) | -30.14%3.31M | -10.09%3.31M | ---- | -9.06%5.9M | 130.68%4.74M | 52.73%3.69M | -26.71%985.81K | 37.82%6.49M | --2.06M | 135.50%2.41M |
| -Interest Income (Financial expense) | -39.92%-490.92M | -77.97%-370.79M | -98.55%-166.46M | -23.84%-477.14M | -41.10%-350.86M | -24.25%-208.35M | 9.48%-83.84M | -4.85%-385.28M | 13.39%-248.67M | 10.71%-167.69M |
| Research and development | 22.10%4.55B | 30.30%3.04B | 6.21%1.22B | 1.38%4.95B | 6.52%3.73B | 6.73%2.33B | 14.05%1.15B | -17.78%4.89B | -15.56%3.5B | -15.36%2.18B |
| Credit Impairment Loss | -365.08%-14.29M | -330.24%-37.5M | -486.75%-12.98M | 165.65%17.25M | 82.97%-3.07M | 141.12%16.29M | 121.54%3.36M | -749.71%-26.28M | 32.89%-18.04M | -12.90%-39.61M |
| Asset Impairment Loss | 172.78%9.25M | --15.82M | --109.56K | 26.91%-107.22M | ---12.71M | ---- | ---- | -958.25%-146.68M | ---- | ---- |
| Other net revenue | 31.90%245.97M | 7.20%140.04M | -12.17%51.39M | -47.88%304.27M | -32.36%186.48M | -17.62%130.64M | 31.86%58.51M | 5.71%583.77M | 42.90%275.7M | 71.44%158.58M |
| Fair value change income | 126.64%9.53M | 127.30%7.54M | 293.79%7.34M | -176.15%-58.26M | -2,111.84%-35.77M | -271.47%-27.62M | 63.13%-3.79M | 111.14%76.5M | 96.46%-1.62M | 254.47%16.11M |
| Invest income | -171.67%-31.42M | -68.86%-16.14M | -98.14%615.9K | -112.69%-49.16M | -110.77%-11.57M | -117.08%-9.56M | 12.32%33.1M | 81.49%387.36M | -36.09%107.41M | -45.20%55.98M |
| -Including: Investment income associates | -15.10%-54.23M | 17.77%-34.38M | ---- | -15.40%-72.7M | ---47.11M | ---41.8M | ---- | -807.71%-63M | ---- | ---- |
| Asset deal income | -52.58%2.15M | -22.72%2.02M | 26.53%1.62M | -42.22%3.16M | 1,956.49%4.53M | 665.72%2.61M | 161.38%1.28M | 62.36%5.47M | -92.81%220.44K | -120.18%-460.98K |
| Other revenue | 10.48%270.74M | 13.02%168.31M | 122.67%54.68M | 73.45%498.49M | 30.54%245.07M | 17.67%148.92M | -39.00%24.56M | -7.00%287.4M | 99.03%187.73M | 276.79%126.56M |
| Operating profit | 35.62%5.35B | 55.04%3.98B | 21.69%1.64B | 19.41%4.91B | 7.93%3.94B | 7.15%2.57B | -1.56%1.34B | -11.85%4.11B | -28.02%3.65B | -25.67%2.4B |
| Add:Non operating Income | 137.84%5.79M | 94.17%3.13M | -53.56%198.81K | 82.46%3.8M | 73.51%2.43M | 70.07%1.61M | 17.45%428.07K | -6.35%2.08M | -54.21%1.4M | -39.84%948.61K |
| Less:Non operating expense | 101.19%264.34M | 297.98%236.31M | 564.84%133.7M | 69.42%246.59M | 10.18%131.39M | 24.45%59.38M | 2,876.16%20.11M | -27.49%145.55M | -19.04%119.24M | -52.78%47.71M |
| Total profit | 33.43%5.09B | 49.32%3.75B | 13.42%1.5B | 17.60%4.67B | 7.88%3.81B | 6.83%2.51B | -2.98%1.32B | -11.15%3.97B | -28.30%3.53B | -24.80%2.35B |
| Less:Income tax cost | 30.18%470.41M | 45.68%323.47M | 47.80%135.02M | 153.86%389.29M | -17.49%361.35M | -21.76%222.04M | -41.86%91.36M | 965.50%153.35M | -40.57%437.95M | -39.00%283.8M |
| Net profit | 33.77%4.62B | 49.67%3.43B | 10.87%1.37B | 12.13%4.28B | 11.47%3.45B | 10.75%2.29B | 2.08%1.23B | -14.92%3.82B | -26.14%3.1B | -22.32%2.07B |
| Net profit from continuing operation | 33.77%4.62B | 49.67%3.43B | 10.87%1.37B | 12.13%4.28B | 11.47%3.45B | 10.75%2.29B | 2.08%1.23B | -14.92%3.82B | -26.14%3.1B | -22.32%2.07B |
| Less:Minority Profit | 85.73%-3.25M | 79.75%-3.62M | 74.79%-1.44M | 73.02%-24.62M | 70.59%-22.75M | 65.17%-17.86M | 80.07%-5.72M | -97.51%-91.23M | -405.50%-77.34M | -886.91%-51.27M |
| Net profit of parent company owners | 32.98%4.62B | 48.67%3.43B | 10.48%1.37B | 10.14%4.3B | 9.47%3.47B | 8.91%2.31B | 0.17%1.24B | -13.77%3.91B | -24.57%3.17B | -20.55%2.12B |
| Earning per share | ||||||||||
| Basic earning per share | 32.73%0.73 | 50.00%0.54 | 10.53%0.21 | 11.48%0.68 | 10.00%0.55 | 9.09%0.36 | 0.00%0.19 | -14.08%0.61 | -24.24%0.5 | -21.43%0.33 |
| Diluted earning per share | 32.73%0.73 | 50.00%0.54 | 10.53%0.21 | 11.48%0.68 | 10.00%0.55 | 9.09%0.36 | 0.00%0.19 | -14.08%0.61 | -24.24%0.5 | -21.43%0.33 |
| Other composite income | -190.19%-12.63M | -100.08%-17.23K | 69.90%-5.93M | 12.43%17.84M | 311.21%14M | 659.72%22.51M | -14,648.05%-19.69M | 302.41%15.87M | -672.97%-6.63M | -1,273.58%-4.02M |
| Other composite income of parent company owners | -205.33%-11.5M | -104.12%-772.84K | 66.49%-6.14M | 8.96%16.09M | 246.37%10.92M | 505.91%18.74M | -72,524.52%-18.33M | 300.53%14.77M | -948.39%-7.46M | -12,147.55%-4.62M |
| Other composite income of minority owners | -136.66%-1.13M | -79.95%755.61K | 115.94%216.54K | 59.17%1.75M | 272.75%3.09M | 532.90%3.77M | -1,155.38%-1.36M | 331.60%1.1M | 665.88%828.16K | 333.43%595.53K |
| Total composite income | 32.86%4.6B | 48.22%3.43B | 12.18%1.36B | 12.13%4.3B | 12.16%3.47B | 12.06%2.31B | 0.46%1.21B | -14.41%3.83B | -26.29%3.09B | -22.47%2.06B |
| Total composite income of parent company owners | 32.24%4.61B | 47.44%3.43B | 11.63%1.36B | 10.13%4.32B | 10.07%3.48B | 10.04%2.33B | -1.31%1.22B | -13.30%3.92B | -24.74%3.17B | -20.72%2.11B |
| Total composite income of minority owners | 77.74%-4.38M | 79.70%-2.86M | 82.70%-1.22M | 74.63%-22.87M | 74.30%-19.66M | 72.20%-14.09M | 75.43%-7.07M | -93.16%-90.14M | -395.35%-76.52M | -829.79%-50.68M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Suya Jincheng Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Suya Jincheng Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
